Clinical trial
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in a Natalizumab Treated Population With Active Control Assessment
NCT01626248 is registered in ClinicalTrials.gov with John F. Foley, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in a Natalizumab Treated Population With Active Control Assessment
- Lead sponsor
- John F. Foley, MD
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- April 30, 2013
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.